Is Atara Biotherapeutics, Inc. (ATRA) a Buy, Sell, or Hold?
NASDAQ : ATRA
Atara Biotherapeutics, Inc. — Analyst Ratings
$8.94 USD
$0.33 (3.83%)
- Volume
- 29.23K
- Average Volume
- 1.43M
- Market Capitalization
- $80.55M
- P/E Ratio
- -13.55
- Dividend Yield
- 0.00%
- Price Target
- $13.00
- Year High
- $19.15
- Year Low
- $3.92
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.16
Analyst Consensus Summary
Consensus Rating
Sell
13 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-31.2%
vs Current Price
Price Target
$13.00
Average TargetPrice Target Range
Lowest Target
$13.00
-31.2% DOWNSIDE
Average Target
$13.00
Median Estimate
Highest Target
$13.00
-31.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 7 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Benjamin Burnett | $10 | $7.58 | 2024-11-13 09:10 AM | 31.9% |
| Mizuho Securities | Salim Syed | $18 | $6.83 | 2024-08-16 04:55 AM | 163.5% |